Search results for "count"

showing 10 items of 5058 documents

Short-term Follow-up after Implantation of a Foldable Iris-Fixated Intraocular Lens in Phakic Eyes

2005

Objective To evaluate efficiency, predictability, stability, complications, and patient satisfaction after implantation of a foldable iris-fixated phakic intraocular lens (PIOL) for the correction of myopia. Design Prospective, nonrandomized, comparative (self-controlled) trial. Participants Forty-one eyes of 22 myopic patients aged 18 to 56 years (mean, 36 years) with average sphere of −8.2±2.01 diopters (D; range, −12.25 to −3.75 D) and average preoperative cylinder of −0.90±0.62 D (range, −2.50 to 0.00 D) were enrolled in this prospective study. Methods All eyes underwent implantation of a foldable iris-fixated PIOL with an optical zone of 6.0 mm. The follow-up was 6 months in all cases.…

AdultMaleIntraocular pressuremedicine.medical_specialtyVisual acuityAdolescentgenetic structuresmedicine.medical_treatmentVisual AcuityIrisCell CountIntraocular lensProsthesis DesignPhakic intraocular lensLens Implantation IntraocularOphthalmologyLens CrystallineMyopiaHumansMedicineProspective StudiesIris (anatomy)Intraoperative ComplicationsProspective cohort studyIntraocular PressureDioptreLenses Intraocularbusiness.industryEndothelium CornealMiddle Agedeye diseasesIndirect ophthalmoscopyOphthalmologymedicine.anatomical_structureFemalesense organsmedicine.symptombusinessFollow-Up StudiesOphthalmology
researchProduct

Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect

1986

Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect. Cellular immune responses in vitro were studied in 24 patients on chronic hemodialysis and 16 healthy volunteers with normal kidney function. Patients on maintenance hemodialysis had lymphopenia with diminished numbers of both T4 + and T8 + T-lymphocytes. The T4/T8 ratios were within the normal range. Peripheral blood lymphocytes (PBL) showed a diminished proliferative response upon stimulation with concanavalin A, phytohemagglutinin and poke weed mitogen. When cell surface antigens were used for stimulation (mixed lymphocyte culture) uremic lymphocytes also showed a lower proliferation rate. Although…

AdultMaleIsoantigensT-LymphocytesLymphocyteT cellLymphocyte CooperationRenal functionStimulationchemical and pharmacologic phenomenaLymphocyte ActivationLeukocyte CountImmune systemmedicineHumansLymphocytesImmunodeficiencyAgedUremiaB-LymphocytesImmunity Cellularbiologybusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseIn vitromedicine.anatomical_structureNephrologyConcanavalin AAntibody FormationImmunologybiology.proteinInterleukin-2Kidney Failure ChronicFemaleMitogensbusinessKidney International
researchProduct

Impact of Corneoscleral Contact Lens Usage on Corneal Biomechanical Parameters in Keratoconic Eyes

2019

Objective To analyze the changes in corneal biomechanical parameters of keratoconic eyes with and without intracorneal ring segment (ICRS) implants after 1 year of corneoscleral contact lens (CScL) wear. Methods Seventy-four eyes of 74 patients were divided into three groups: healthy subjects (29 eyes, control group), and 2 groups of subjects with keratoconic eyes (one group of 20 eyes with ICRS implants and one of 25 eyes without them), which were fitted with CScL. Corneal hysteresis (CH), corneal resistance factor (CRF), and corneal-compensated intraocular pressure (IOPcc) were evaluated before fitting CScL and after 1 year of CScL wear. In addition, endothelial cell count (ECC) and centr…

AdultMaleKeratoconusIntraocular pressuremedicine.medical_specialtygenetic structuresContact LensesCorneal StromaKeratoconusEndothelial cell countCorneaProsthesis ImplantationCorneoscleral contact lensCorneal hysteresisTonometry OcularYoung Adult03 medical and health sciences0302 clinical medicineProsthesis FittingCorneaOphthalmologyHumansMedicineProspective StudiesIntracorneal ring segmentIntraocular Pressurebusiness.industryHealthy subjectsProstheses and Implantsmedicine.diseaseElasticityeye diseasesBiomechanical PhenomenaOphthalmologyCross-Sectional Studiesmedicine.anatomical_structure030221 ophthalmology & optometryFemalesense organsbusiness030217 neurology & neurosurgeryEye & Contact Lens: Science & Clinical Practice
researchProduct

Modification of Peripheral Blood T-Lymphocyte Surface Receptors and Langerhans Cell Numbers in Hereditary Angioedema

1986

Hereditary angioedema (HAE) is a disease related to a complement disorder, namely a deficiency of C1 esterase inhibitor. Complement-split products are implicated in the regulation of the immune response, and we have compared some immunologic parameters between HAE and normal individuals. T-lymphocytes with receptors for IgG were increased in HAE, but no difference in T-cell suppressor activity for B-cells was detected. Furthermore, increased IgG receptor expression was not accompanied by any significant changes in the ratios of OKT4- and OKT8-defined antigens. Numbers of peripheral mononuclear cells (MNC) detected by alpha-naphthyl acetate esterase (ANAE) staining positivity were not signif…

AdultMaleLangerhans cellT-LymphocytesReceptor expressionReceptors Antigen T-CellFluorescent Antibody TechniqueCell CountT-Lymphocytes RegulatoryPeripheral blood mononuclear cellMonocytesLeukocyte CountImmune systemmedicineHumansAngioedemaReceptorSkinChemistryAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseComplement systemmedicine.anatomical_structureLangerhans CellsHereditary angioedemaImmunologyFemaleCell activationAmerican Journal of Clinical Pathology
researchProduct

Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up study in Finland.

2015

Summary. Background. Systolic blood pressure, total cholesterol and smoking are known predictors of cardiovascular disease (CVD) mortality. Less is known about the effect of lifetime accumulation and changes of risk factors over time as predictors of CVD mortality, especially in very long follow-up studies. Methods. Data from the Finnish cohorts of the Seven Countries Study were used. The baseline examination was in 1959 and seven re-examinations were carried out approximately in five-year intervals. Cohorts were followed up for mortality until the end of 2011. Time-dependent Cox models with regular time-updated risk factors, time-dependent averages of risk factors and latest changes in ris…

AdultMaleLongitudinal studyTime FactorsEpidemiologyBlood PressureDiseaseBody Mass IndexSeven Countries StudyRisk FactorsMedicineHumansRisk factorExerciseFinlandAgedAged 80 and overta112business.industryProportional hazards modelSmokinglongitudinal studyAge FactorsGeneral Medicineta3142riskitekijätMiddle AgedmortalityCumulative riskBlood pressureCholesterolCardiovascular Diseasessydän- ja verisuonitauditbusinessBody mass indexDemographyFollow-Up StudiesInternational journal of epidemiology
researchProduct

HLA-B8,DR3 haplotype affects lymphocyte blood levels

1997

The number of lymphocytes in the blood is constant, pointing to an effective control of circulating lymphocyte values. The mechanisms of this regulation are uncertain, although it is likely that the number of blood lymphocytes is conditioned by hormones, homing factors and cytokines whose production is at least partly restrained by genetic factors. Particularly genetic factors linked to major histocompatibility complex (MHC) appear to be involved. In human beings a decreased number of blood lymphocytes has been described in healthy subjects carrying the Human Leucocyte Antigens (HLA) haplotype HLA-B8,DR3. In the present study, to inquire into the mechanisms of this lymphocyte decreased numb…

AdultMaleLymphocyteImmunologyApoptosisHuman leukocyte antigenMajor histocompatibility complexHLA-B8 AntigenHLA-DR3 AntigenLymphocyte subpopulationsmedicineHumansLymphocyte CountLymphocytesAgedbiologyHaplotypeGeneral MedicineMiddle Agedmedicine.anatomical_structureHaplotypesImmunologybiology.proteinLeucocyte antigensFemaleHormoneHoming (hematopoietic)Immunological Investigations
researchProduct

Identification of Candida dubliniensis among oral yeast isolates from an italian population of human immunodeficiency virus-infected (HIV +) subjects

2002

Candida dubliniensis, an emerging oral pathogen, phenotypically resembles Candida albicans so closely that it is easily misidentified as such. The aim of the present study was to evaluate the usefulness of two phenotypic methods, growth at 45 degrees C and 2,3,5-triphenyltetrazolium chloride (TTC) reduction, for confirming presumptive identification of C. dubliniensis and C. albicans by colony color on CHROMagar Candida (CAC) medium. A combination of these methods was used to establish the prevalence of oral C. dubliniensis in an Italian population of 45 human immunodeficiency virus (HIV)-infected subjects. Twenty-two samples (48.9%) were positive for yeasts on CAC medium producing a total …

AdultMaleMicrobiology (medical)IdentificationSettore MED/07 - Microbiologia E Microbiologia ClinicaAntifungal AgentsImmunologyColony Count MicrobialTetrazolium SaltsHIV InfectionsPolymerase Chain ReactionMicrobiologyCandidiasis OralDrug Resistance FungalSettore MED/28 - Malattie OdontostomatologicheCandida albicansHumansColoring AgentsDNA FungalFluconazoleCandidaMouthTemperatureHIVMiddle AgedCulture MediaOral cavityAgarPhenotypeChromogenic CompoundsItalyCandida dubliniensiDentistry (all)Female
researchProduct

Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients

2000

Abstract In patients with chronic hepatitis C and HIV infection, responsiveness to the standard schedule of α-interferon (IFN) is unsatisfactory. To quantify the effectiveness of tailoring IFN dosage according to HCV viral load under treatment, we enrolled 41 patients (M/F 32/9) chronically coinfected by HCV and HIV with chronic liver disease. All were former i.v. drug addicts, with a mean age of 32±4 years, and had clinical and histological evidence of chronic hepatitis (10% with cirrhosis). The CDC stage was A1 in five, A2 in 14, A3 in eight, B2 in eight, B3 in three and C3 in three. Twenty four patients were on triple therapy with protease inhibitors, 11 were on two-drug anti-HIV regimen…

AdultMaleMicrobiology (medical)medicine.medical_specialtyCirrhosisSubstance-Related DisordersAlpha interferonHIV InfectionsHepacivirusChronic liver diseaseAntiviral AgentsGastroenterologyLiver diseaseInternal medicinemedicineHumansPharmacology (medical)Interferon alfabusiness.industryHIVInterferon-alphavirus diseasesGeneral MedicineHepatitis CHepatitis C ChronicViral Loadmedicine.diseaseCD4 Lymphocyte CountTreatment OutcomeInfectious DiseasesImmunologyPatient ComplianceFemaleViral diseasebusinessViral loadmedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

Biaxial Microincision versus Coaxial Small-Incision Clear Cornea Cataract Surgery

2005

Objective To compare clinical outcomes of biaxial microincision (1.5 mm) and coaxial small-incision (2.75 mm) clear cornea cataract surgery. Design Randomized controlled clinical trial. Participants Seventy eyes of 70 patients were examined at a German university eye hospital. Intervention The 70 patients (70 eyes) were assigned randomly (1:1) to a biaxial or conventional coaxial incision group. Both groups underwent phacoemulsification using pulsed ultrasound energy with variable duty cycles, followed by microincision intraocular lens implantation. Main Outcome Measures Best-corrected visual acuity (BCVA), astigmatism, laser flare photometry value, effective phacoemulsification time (EPT),…

AdultMaleMicrosurgerymedicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentVisual AcuityCell CountIntraocular lensAstigmatismCorneaLens Implantation IntraocularOphthalmologymedicineHumansProspective StudiesDioptreAgedAged 80 and overPhacoemulsificationbusiness.industryEndothelium CornealAstigmatismPhacoemulsificationMiddle AgedCataract surgerymedicine.diseaseOphthalmologyFemalemedicine.symptomCoaxialbusinessSurgical incisionOphthalmology
researchProduct

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral b…

2001

We examined safety and efficacy of STI-571 in 24 bcr/abl-positive patients with CML post PBSCT. At start of STI-571 therapy, nine patients presented in blast crisis (BC) or in accelerated phase (AP), and 15 in chronic phase (CP). Patients were evaluated for hematologic, cytogenetic and molecular response, survival and toxicity. In general, STI-571 was well tolerated in this heavily pretreated group of patients with a non-hematologic and hematologic toxicity profile similar to that observed in a previous phase I trial at comparable doses. Five of nine patients with CML in transformation (AP, BC) were evaluable for hematologic response. Two of five patients had transient reductions in WBC and…

AdultMaleOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentFusion Proteins bcr-ablAntineoplastic AgentsPhiladelphia chromosomeTransplantation AutologousPiperazinesLeukemia Myelogenous Chronic BCR-ABL Positivehemic and lymphatic diseasesInternal medicinemedicineHumansEnzyme InhibitorsChemotherapyABLbusiness.industryHematopoietic Stem Cell Transplantationbreakpoint cluster regionHematologyMiddle AgedProtein-Tyrosine Kinasesmedicine.diseaseCombined Modality TherapyHematologic ResponseBlood Cell CountPyrimidinesTreatment OutcomeImatinib mesylateOncologyBenzamidesToxicityImmunologyImatinib MesylateFemaleComplicationbusinessLeukemia
researchProduct